Journal for ImmunoTherapy of Cancer (Nov 2020)
633 Dual-targeting of 4–1BB and OX40 with an ADAPTIR™ bispecific antibody enhances anti-tumor responses to solid tumor
- Michelle Nelson,
- Robert Miller,
- Gabriele Blahnik-Fagan,
- Lauren Loh,
- Danielle Van Citters,
- Lynda Misher,
- Megan Sprague,
- Maria Dasovich,
- Irene Barber,
- Kathy Maggiora,
- Franz Gruswitz,
- Brian Woodruff,
- Kelsey Huntington,
- Aelish Guinn,
- Megan Aguilar,
- Mollie Daugherty,
- Elizabeth Haglin,
- Jane Gross,
- Peter Pavlik,
- Catherine McMahan,
- David Bienvenue,
- Gabriela Hernandez-Hoyos
Affiliations
- Michelle Nelson
- 2Medical University of South Carolina, Charleston, SC, USA
- Robert Miller
- Aptevo Therapeutics, Seattle, WA, USA
- Gabriele Blahnik-Fagan
- Aptevo Therapeutics, Seattle, WA, USA
- Lauren Loh
- Aptevo Therapeutics, Seattle, WA, USA
- Danielle Van Citters
- Aptevo Therapeutics, Seattle, WA, USA
- Lynda Misher
- Aptevo Therapeutics, Seattle, WA, USA
- Megan Sprague
- Aptevo Therapeutics, Seattle, WA, USA
- Maria Dasovich
- Aptevo Therapeutics, Seattle, WA, USA
- Irene Barber
- Aptevo Therapeutics, Seattle, WA, USA
- Kathy Maggiora
- Aptevo Therapeutics, Seattle, WA, USA
- Franz Gruswitz
- Aptevo Therapeutics, Seattle, WA, USA
- Brian Woodruff
- Aptevo Therapeutics, Seattle, WA, USA
- Kelsey Huntington
- Aptevo Therapeutics, Seattle, WA, USA
- Aelish Guinn
- Aptevo Therapeutics, Seattle, WA, USA
- Megan Aguilar
- Aptevo Therapeutics, Seattle, WA, USA
- Mollie Daugherty
- Aptevo Therapeutics, Seattle, WA, USA
- Elizabeth Haglin
- Aptevo Therapeutics, Seattle, WA, USA
- Jane Gross
- Aptevo Therapeutics, Seattle, WA, USA
- Peter Pavlik
- Aptevo Therapeutics, Seattle, WA, USA
- Catherine McMahan
- Aptevo Therapeutics, Seattle, WA, USA
- David Bienvenue
- Aptevo Therapeutics, Seattle, WA, USA
- Gabriela Hernandez-Hoyos
- Aptevo Therapeutics, Seattle, WA, USA
- DOI
- https://doi.org/10.1136/jitc-2020-SITC2020.0633
- Journal volume & issue
-
Vol. 8,
no. Suppl 3
Abstract
No abstracts available.
